Double - stranded ribonucleic acid for adjuvants ; US 20150307884 A 1 Adjuvant compositions ; WO 2003028656 A 2 : shorter form of poly IC Clinical method for the immunomodulatory and vaccine adjuvant use of poly - ICLC and other dsRNAs ; US 7834064 B 2 dsRNAs as influenza virus vaccine adjuvants or immuno - stimulants ; US 20070224219 A 1 Process for the maturation of dendritic cells and a vaccine ; US 7981673 B 2 Topically active compositions of mismatched dsRNAs ; US 5712257 A Treatment of hepatitis with mismatched dsRNA ; US 5906980 A Double - stranded Poly C : Poly ( G / I ) RNA for immunostimulation and cancer treatment ; EP 3083962 A 1 Methods and formulations to achieve tumor targeted double stranded ribonucleic acid mediated cell death ; WO 2014165296 A 1 Polyinosinic acid - polycytidylic acid - based adjuvant ; US 20070160632 A 1 In - situ cancer autovaccination with intra tumoral stabilized dsRNA viral mimic ; US 20090088401 A 1 Novel nucleic acid having adjuvant activity and use thereof ; WO 2012014945 A Improved treatment of cancer using tlr 3 agonists in combination with another therapeutic agent ; WO 2009130301 A 1 : polyA : U or polyLC Double - Stranded Ribonucleic Acid Conjugates And Their Use ; US 20170107517 A 1 Double - stranded ribonucleic acids with rugged physico - chemical structure and highly specific biologic activity ; WO 2010047835 A 2 Immunization strategy to prevent H 1 N 1 infection ; EP 2477652 A 4